Discontinued — last reported Q3 '21
Corporate Functions — Operating Income
Zimmer Biomet Holdings Corporate Functions — Operating Income increased by 6.7% to -$151.2M in Q3 2021 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase in operating loss indicates rising corporate overhead or administrative expenses, while a decrease suggests improved cost management or reduced central support requirements.
Detailed definition
This metric represents the operating income or loss generated by the corporate administrative and support functions that...
Peer comparison
Most large-cap medical device companies report similar unallocated corporate expenses, often labeled as 'Corporate' or 'Other' in segment reporting, which are typically evaluated as a percentage of total revenue to assess administrative leverage.
zbh_segment_corporate_functions_operating_income_lossHistorical Data
| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | -$162M | -$151.2M |
| QoQ Change | — | +6.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's corporate functions — operating income?
- Zimmer Biomet Holdings (ZBH) reported corporate functions — operating income of -$151.2M in Q3 2021.
- What does corporate functions — operating income mean?
- This is the net operating profit or loss resulting from the company's central administrative and corporate support activities.